InVentis Technologies to Distribute TriLink Products in India
News Nov 07, 2014
TriLink BioTechnologies, Inc. has entered into a distribution agreement with inVentis Technologies, an Indian distribution and manufacturing company specializing in the life science and applied science, research, diagnostics and QC market. The agreement allows inVentis to market TriLink’s complete line of nucleic acid-based products. This includes TriLink’s stocked and custom nucleotides, oligonucleotides and mRNA, as well as their CleanAmp™ Hot Start PCR Products.
"With the biotech industry growing rapidly in India, TriLink has been looking for the right opportunity to enter the market. InVentis provides an extensive line of life science products to the biotech and pharmaceutical market and we feel that our high quality nucleic acid-based products will complement their offering and help advance research in the area,” commented TriLink's President and CEO, Richard Hogrefe, Ph.D.
“With the biotechnology industry in India increasingly focused on “OMICS”, InVentis has been looking for a world-class nucleic acid-based product line to fulfill the growing demand in the genomics and molecular biology sector. We anticipate that the market will continue to grow and addition of TriLink products will complement the portfolio offered by InVentis”, stated Founder and BM Singh, Sandeep. “We are delighted to enter into an agreement with TriLink.”
Potential Genetic Mechanism Behind Obesity IdentifiedNews
New research from the Research Triangle suggests that variants in a gene called ankyrin-B -- carried by millions of Americans -- could cause people to put on pounds through no fault of their own.
CRISPR Delivery System Enables Deletion of Disease-causing GenesNews
MIT researchers have developed nanoparticles that can deliver the CRISPR genome-editing system and specifically modify genes in mice.READ MORE
Attacking Telomeres Offers First Effective Glioblastoma TherapyNews
Blocking TRF1 – a telomere protector – interrupts tumour growth and increases survival in various mouse models of glioblastoma.READ MORE